Aprameya Engineering Annual General Meeting
Aprameya Engineering Limited held its 5th Annual General Meeting on August 1, 2026. Seven resolutions including financial adoption and related party transactions were addressed.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Aprameya Engineering Limited held its 5th Annual General Meeting on August 1, 2026. Seven resolutions including financial adoption and related party transactions were addressed.
Aprameya Engineering Limited declared that Regulation 24A secretarial compliance is not applicable as it is listed on NSE Emerge. The filing confirms exemption status.
Aprameya Engineering secured a Rs.5.84 Crore working capital loan from Punjab National Bank. The loan is secured via mortgage of company properties.
Aprameya Medtech partnered with SonoScape for exclusive sales of advanced surgical imaging systems in Southern and Western India. This adds a high-margin medical equipment growth engine to the company's healthcare platform.
Aprameya Engineering reported normalized collections and a transition toward a product-led healthcare platform. The company also entered an exclusive robotic healthcare partnership to drive growth.
Aprameya Engineering reported full-year standalone total income of ₹55.23 Crore for FY26. The board approved audited results and an unmodified auditor's opinion.
Aprameya Engineering Limited appointed Jalan Alkesh & Associates as Secretarial Auditor for its subsidiary, Aprameya Medtech Private Limited. The appointment spans an initial five-year term.
Aprameya Engineering Ltd reported revenue from operations of ₹13 Cr (-89.7% YoY) and a net loss of ₹1.6 Cr for H2 FY26.
Aprameya Engineering reported consolidated annual revenue of ₹55.13 Crore for FY26. The company maintained an unmodified audit opinion across its standalone and consolidated results.
Aprameya Engineering scheduled a board meeting on May 28, 2026, to approve audited annual financial results. The trading window remains closed until May 30, 2026.